{"id":"https://openalex.org/W2885581167","doi":"https://doi.org/10.1158/1538-7445.am2018-2834","title":"Abstract 2834: Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond","display_name":"Abstract 2834: Genomewide CRISPR studies of sequential treatment with CRBN-based degronimids: Insights into the molecular evolution of treatment resistance in myeloma and beyond","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885581167","doi":"https://doi.org/10.1158/1538-7445.am2018-2834","mag":"2885581167"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-2834","doi":"https://doi.org/10.1158/1538-7445.am2018-2834","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2834","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027607604","display_name":"Ryosuke Shirasaki","orcid":"https://orcid.org/0009-0000-5629-1394","observed_orcids":["https://orcid.org/0009-0000-5629-1394"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryosuke Shirasaki","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068511166","display_name":"Sara Gandolfi","orcid":"https://orcid.org/0000-0001-6207-4433","observed_orcids":["https://orcid.org/0000-0001-6207-4433"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sara Gandolfi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005661878","display_name":"Ricardo De Matos Simoes","orcid":"https://orcid.org/0000-0002-1700-5276","observed_orcids":["https://orcid.org/0000-0002-1700-5276"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ricardo De Matos Simoes","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023676277","display_name":"Geoffrey M. Matthews","orcid":"https://orcid.org/0000-0002-2804-2021","observed_orcids":["https://orcid.org/0000-0002-2804-2021"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Geoffrey Matthews","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049971068","display_name":"Sondra L. Downey-Kopyscinski","orcid":"https://orcid.org/0000-0003-4203-3583","observed_orcids":["https://orcid.org/0000-0003-4203-3583"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sondra Downey","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027278060","display_name":"Olga Dashevsky","orcid":"https://orcid.org/0000-0001-8905-1872","observed_orcids":["https://orcid.org/0000-0001-8905-1872"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga Dashevsky","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100666803","display_name":"Huihui Tang","orcid":"https://orcid.org/0000-0003-2580-4016","observed_orcids":["https://orcid.org/0000-0003-2580-4016"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tang Huihui","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023112790","display_name":"Michal Sheffer","orcid":"https://orcid.org/0000-0001-5934-9950","observed_orcids":["https://orcid.org/0000-0001-5934-9950"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michal Sheffer","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074250265","display_name":"Eugen Dhimolea","orcid":"https://orcid.org/0000-0002-8445-5509","observed_orcids":["https://orcid.org/0000-0002-8445-5509"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eugen Dhimolea","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108696080","display_name":"Megan A. Bariteau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megan Bariteau","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011297308","display_name":"Jeffrey Sorrell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Sorrel","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019773497","display_name":"Nick Kwiatkowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nick Kwiatkowski","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078049772","display_name":"Thinghu Zhang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thinghu Zhang","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022352605","display_name":"Nathanael S. Gray","orcid":"https://orcid.org/0000-0001-5354-7403","observed_orcids":["https://orcid.org/0000-0001-5354-7403"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nathanael Gray","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012712111","display_name":"Constantine S. Mitsiades","orcid":"https://orcid.org/0000-0003-2321-8005","observed_orcids":["https://orcid.org/0000-0003-2321-8005"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Constantine Mitsiades","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"2834","last_page":"2834"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.9726999998092651,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.019999999552965164,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.7229999899864197},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.9120000004768372},{"id":"https://openalex.org/keywords/crispr-cas9-screening","display_name":"CRISPR-Cas9 screen","score":0.7369999885559082},{"id":"https://openalex.org/keywords/bet-proteins","display_name":"BET proteins","score":0.6449999809265137},{"id":"https://openalex.org/keywords/cdk9","display_name":"CDK9","score":0.7599999904632568},{"id":"https://openalex.org/keywords/loss-of-function","display_name":"loss of function","score":0.5009999871253967},{"id":"https://openalex.org/keywords/cereblon","display_name":"cereblon","score":0.5130000114440918},{"id":"https://openalex.org/keywords/ubiquitination","display_name":"ubiquitination","score":0.652999997138977},{"id":"https://openalex.org/keywords/proteasomal-degradation","display_name":"proteasomal degradation","score":0.9120000004768372},{"id":"https://openalex.org/keywords/signalosome","display_name":"signalosome","score":0.6639999747276306},{"id":"https://openalex.org/keywords/ddb1","display_name":"DDB1","score":0.7200000286102295},{"id":"https://openalex.org/keywords/cand1","display_name":"CAND1","score":0.8569999933242798}],"concepts":[{"id":"https://openalex.org/C98108389","wikidata":"https://www.wikidata.org/wiki/Q412563","display_name":"CRISPR","level":3,"score":0.7167577147483826},{"id":"https://openalex.org/C134459356","wikidata":"https://www.wikidata.org/wiki/Q4274835","display_name":"Ubiquitin ligase","level":4,"score":0.6922910213470459},{"id":"https://openalex.org/C2778540781","wikidata":"https://www.wikidata.org/wiki/Q21112029","display_name":"Cereblon","level":5,"score":0.6830717325210571},{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.6509512662887573},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5022270679473877},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.46760809421539307},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.4440406560897827},{"id":"https://openalex.org/C132455925","wikidata":"https://www.wikidata.org/wiki/Q16965677","display_name":"Cas9","level":4,"score":0.4410959780216217},{"id":"https://openalex.org/C2775895488","wikidata":"https://www.wikidata.org/wiki/Q5251856","display_name":"Degron","level":5,"score":0.4245024025440216},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.41790610551834106},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.41748854517936707},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3903564512729645},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3479042053222656},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.33259761333465576},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.17065897583961487}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-2834","doi":"https://doi.org/10.1158/1538-7445.am2018-2834","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-2834","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.800000011920929,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2916253374","https://openalex.org/W2954786200","https://openalex.org/W2883654450","https://openalex.org/W2499149931","https://openalex.org/W3119591201","https://openalex.org/W2585129131","https://openalex.org/W2981222059","https://openalex.org/W2950091955","https://openalex.org/W2973147210","https://openalex.org/W2989666329"],"abstract_inverted_index":{"Abstract":[0],"Degronimids":[1],"are":[2,323],"bifunctional":[3],"agents":[4],"in":[5,76,246,271,344,359,430],"which":[6,18,218],"a":[7,103,175],"thalidomide-like":[8],"moiety":[9],"brings":[10],"the":[11,21,80,83,145,164,185,208,238,247,250,274,287,342,365,424,438],"E3":[12],"ligase":[13],"CRBN":[14,135,149,199,239,266,296],"close":[15],"to":[16,20,28,55,90,182,184,192,204,234,298,314,325,348],"proteins":[17,46,352],"bind":[19],"second":[22],"functionality":[23],"of":[24,33,70,87,102,132,144,163,178,187,195,198,207,237,249,265,276,278,290,303,321,328,333,336,346,369,416,427,437],"these":[25,34,279,291,360],"compounds,":[26],"leading":[27],"ubiquitination":[29],"and":[30,39,48,64,129,137,160,355,432],"proteasomal":[31],"degradation":[32,186,206],"latter":[35],"proteins.":[36],"Our":[37,338],"groups":[38],"others":[40],"have":[41],"examined":[42],"BET":[43],"bromodomain":[44],"(BRD)-containing":[45],"BRD2,3,":[47],"4":[49,113],"(dBET6)":[50],"or":[51,142,200,231,316],"CDK9":[52],"(ZZ1-33,":[53],"referred":[54],"herein":[56],"as":[57],"dCDK9).":[58],"We":[59],"documented":[60],"that":[61,147,174,214,260],"both":[62,123],"dBET":[63,232],"dCDK9":[65,230],"compounds":[66],"trigger":[67],"rapid":[68],"induction":[69],"multiple":[71,161],"myeloma":[72,431],"(MM)":[73],"cell":[74,283],"death":[75],"vitro.":[77],"To":[78],"dissect":[79],"mechanisms":[81,345],"regulating":[82],"response":[84],"vs.":[85],"resistance":[86,313,347,429],"MM":[88,282],"cells":[89,217,294,371],"degronimids,":[91],"we":[92,126,212],"performed":[93],"genome-wide":[94],"CRISPR/Cas9-based":[95],"gene":[96],"editing":[97],"screens":[98,121,362],"using":[99],"lentiviral":[100],"particles":[101],"pooled":[104],"sgRNA":[105],"library":[106],"(Brunello;":[107],"~70,000":[108],"sgRNAs":[109,133,253],"against":[110],"~20,000":[111],"genes;":[112],"sgRNAs/gene;":[114],"plus":[115],"additional":[116],"non-targeting":[117],"control":[118],"sgRNAs).":[119],"In":[120],"with":[122,228,243,252,295,419],"CRBN-mediated":[124,319],"\"degraders\",":[125],"observed":[127,213],"consistent":[128],"pronounced":[130],"enrichment":[131,236],"for":[134,254,262,281,353,375,441],"itself,":[136],"also":[138,308],"other":[139,255,300],"upstream":[140],"components":[141],"regulators":[143,264,335],"complex":[146,166],"regulates":[148],"function":[150,196],"(e.g.":[151,158],"DDB1,":[152],"CAND1),":[153],"E2":[154],"ubiquitin":[155],"conjugating":[156],"enzymes":[157],"UBE2G1)":[159],"members":[162],"signalosome":[165],"(COPS7A,":[167],"COPS7B,":[168],"GPS1,":[169],"et.c.).":[170],"These":[171,257],"results":[172],"indicate":[173],"primary":[176],"mechanism":[177],"degronimid-resistance":[179],"relates":[180],"not":[181],"adaptation":[183],"their":[188],"respective":[189],"targets,":[190],"but":[191,273],"via":[193],"loss":[194],"(LOF)":[197],"its":[201,317,334],"positive":[202,263],"regulators,":[203],"prevent":[205],"degronimid":[209],"target(s).":[210],"Also,":[211],"dCDK9-resistant":[215],"MM.1S":[216],"established":[219],"from":[220],"our":[221],"CRISPR":[222,339,361,414],"screen,":[223],"upon":[224],"more":[225],"extensive":[226],"treatment":[227,418,428],"either":[229],"led":[233],"further":[235],"sgRNA-containing":[240],"tumor":[241,370],"cells,":[242],"significant":[244],"decrease":[245],"fraction":[248],"population":[251],"hits.":[256],"observations":[258],"imply":[259],"LOF":[261,297,327,374],"activity":[267],"may":[268,285,307],"provide":[269],"protection":[270],"short-term,":[272],"role":[275],"several":[277],"genes":[280],"proliferation/survival":[284],"limit":[286],"longer-term":[288],"fitness":[289],"populations,":[292],"allowing":[293],"outcompete":[299],"potential":[301],"forms":[302],"resistance.":[304],"This":[305],"finding":[306],"indirectly":[309],"explain":[310],"why":[311],"clinical":[312],"thalidomide":[315],"derivatives,":[318],"\"degraders":[320],"IKZF1/IKF3,":[322],"reported":[324],"involve":[326],"CRBN,":[329],"rather":[330],"than":[331],"most":[332],"CRBN.":[337],"studies":[340,415],"document":[341],"concordance":[343],"\"degronimids\"":[349],"targeting":[350],"different":[351,376],"degradation;":[354],"how":[356],"time-course":[357],"analyses":[358],"can":[363],"reveal":[364],"dynamics":[366],"between":[367],"sub-populations":[368],"harboring":[372],"sgRNA-mediated":[373],"candidate":[377],"genes.":[378],"Citation":[379],"Format:":[380],"Ryosuke":[381],"Shirasaki,":[382],"Sara":[383],"Gandolfi,":[384],"Ricardo":[385],"De":[386],"Matos":[387],"Simoes,":[388],"Geoffrey":[389],"Matthews,":[390],"Sondra":[391],"Downey,":[392],"Olga":[393],"Dashevsky,":[394],"Tang":[395],"Huihui,":[396],"Michal":[397],"Sheffer,":[398],"Eugen":[399],"Dhimolea,":[400],"Megan":[401],"Bariteau,":[402],"Jeffrey":[403],"Sorrel,":[404],"Nick":[405],"Kwiatkowski,":[406],"Thinghu":[407],"Zhang,":[408],"Nathanael":[409],"Gray,":[410],"Constantine":[411],"Mitsiades.":[412],"Genomewide":[413],"sequential":[417],"CRBN-based":[420],"degronimids:":[421],"Insights":[422],"into":[423],"molecular":[425],"evolution":[426],"beyond":[433],"[abstract].":[434],"In:":[435],"Proceedings":[436],"American":[439],"Association":[440],"Cancer":[442,455],"Research":[443],"Annual":[444],"Meeting":[445],"2018;":[446],"2018":[447],"Apr":[448],"14-18;":[449],"Chicago,":[450],"IL.":[451],"Philadelphia":[452],"(PA):":[453],"AACR;":[454],"Res":[456],"2018;78(13":[457],"Suppl):Abstract":[458],"nr":[459],"2834.":[460]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2018-08-22T00:00:00"}